Personal information

Verified email domains

United Kingdom

Activities

Employment (1)

University of Bristol: Bristol, Bristol, GB

2015-03-07 to present | Professor of Clinical Epidemiology (Bristol Medical School)
Employment
Source: Self-asserted source
Penny Whiting

Funding (16)

Expanding the eligibility criteria for a no-biopsy diagnosis for coeliac disease in adults and children: Individual participant data review and cost-effectiveness analysis.

2024-09-01 to 2026-08-31 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR156881
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Production of Evidence Syntheses for the Evidence Synthesis Programme

2023-04-01 to 2028-03-31 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR153861
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack [DAP65]

2022-07-15 to 2023-05-24 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR135620
Source: Self-asserted source
Penny Whiting via DimensionsWizard

The benefits, harms and costs of surveillance for hepatocellular carcinoma in people with cirrhosis: synthesis of observational and diagnostic test accuracy data and cost –utility analysis

2022-06 to present | Grant
NIHR HTA (Southampton, GB)
Source: Self-asserted source
Penny Whiting

Olaparib for adjuvant treatment of high-risk HER2-negative BRCA-positive early breast cancer after chemotherapy [ID3893]

2022-04-26 to 2022-10-11 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR135584
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Research Proposals: Production of Technology Assessment Reviews (TARs) for the National Institute for Health Research (NIHR)

2022-04-01 to 2027-03-31 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR131974
Source: Self-asserted source
Penny Whiting via DimensionsWizard

A Surgical Site Infection Risk Prediction Tool to Enable Targeted Infection Prevention Strategies in Adult Cardiac Surgery

2022-01-01 to 2023-06-30 | Grant
National Institute for Health Research (London, GB)
GRANT_NUMBER: NIHR202620
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Developing evidence based optimal testing strategies to monitor long term conditions in primary care

2021-06-01 to 2026-05-31 | Grant
National Institute for Health Research (London, GB)
GRANT_NUMBER: NIHR201616
Source: Self-asserted source
Penny Whiting via DimensionsWizard

The development of a risk of bias assessment tool for network meta-analysis

2021-04-01 to 2024-03-31 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER: 202010PJT
Source: Self-asserted source
Penny Whiting via DimensionsWizard

The development of a risk of bias assessment tool for network meta-analysis

2021-04-01 to 2024-03-31 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER: 9650190
Source: Self-asserted source
Penny Whiting via DimensionsWizard

What is the optimum strategy for identifying adults and children with coeliac disease? A systematic review and economic models

2020-01-01 to 2021-06-30 | Grant
NIHR Evaluation Trials and Studies Coordinating Centre (Southampton, GB)
GRANT_NUMBER: NIHR129020
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Research to Improve the Detection and Treatment of Latent Tuberculosis Infection (RID-TB)

2018-10-01 to 2023-09-30 | Grant
National Institute for Health Research (London, GB)
GRANT_NUMBER: RP-PG-0217-20009
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Viscoelastic point-of-care testing to assist withthe diagnosis management and monitoringof haemostasis.

2013-08-29 to 2014-05-13 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: 13/38/01
Source: Self-asserted source
Penny Whiting via DimensionsWizard

The ROTEM Delta point-of-care analyser to assist with the diagnosis, management and monitoring of haemostasis during and after surgery.

Source: Self-asserted source
Penny Whiting via DimensionsWizard

Ivacaftor for the Treatment of Patients with Cystic Fibrosis and the G551D Mutation: A systematic review and cost-effectiveness analysis

2012-06-18 to 2012-08-17 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: 12/32/01
Source: Self-asserted source
Penny Whiting via DimensionsWizard

Ivacaftor for the Treatment of Patients with Cystic Fibrosis and the G551D Mutation: A systematic review and cost-effectiveness analysis

Source: Self-asserted source
Penny Whiting via DimensionsWizard